Jacqueline Speed, MD
Urogynecology and Reconstructive Pelvic Surgery · Salem, MANPI 1811314966
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.0%), education and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Axonics, Inc. at 36.5% of the total. Reporting peaked in 2021 at $361 and has fallen 67.6% since, to $117 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in MA, where the typical reported total is $2,944.
Across 11 payments — averaging $113.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$454
- Coopersurgical, Inc.$240
- Procept Biorobotics Corporation$151
- Calyxo, Inc.$136
- Ferring Pharmaceuticals Inc.$136
- Boston Scientific$76
- plus $50 from 1 others
What the payments were for
- Consulting fees$24019%
- Food & beverage$57246%
- Education$43235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 3 | $454 |
| Coopersurgical, Inc. | 1 | $240 |
| Procept Biorobotics Corporation | 2 | $151 |
| Calyxo, Inc. | 2 | $136 |
| Ferring Pharmaceuticals Inc. | 1 | $136 |
| Boston Scientific | 1 | $76 |
| AbbVie | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,244 in reported general payments places this provider in the 30th percentile of 35 urogynecology and reconstructive pelvic surgery providers in Massachusetts.
See all urogynecology and reconstructive pelvic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 272 | $197,010 |
| GemtesaVibegron | 253 | $184,348 |
| Estradiol | 190 | $10,947 |
| Methenamine Hippurate | 118 | $7,733 |
| Mirabegron ErMirabegron | 12 | $6,000 |
| Trospium Chloride | 58 | $4,040 |
| Solifenacin Succinate | 74 | $4,009 |
| Oxybutynin Chloride ErOxybutynin Chloride | 92 | $3,019 |
| Tamsulosin Hcl | 111 | $1,958 |
| Desmopressin Acetate | 38 | $1,608 |
| Cephalexin | 191 | $1,511 |
| Clobetasol Propionate | 29 | $1,388 |
| Amitriptyline Hcl | 78 | $1,209 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 153 | $1,177 |
| Tolterodine Tartrate ErTolterodine Tartrate | 20 | $1,069 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Salem
- Diego IllanesMilford$277K
- Peter RosenblattCambridge$223K
- Eman ElkadryCambridge$130K
- Amos AdelowoWorcester$30K
- Lori JonesBoston$22K
- William WinkelmanCambridge$16K
- Vikas MerchiaBrockton$15K
- John Al JamalBoston$15K
- Youngwu KimBoston$14K
- Jyot SainiWellesley$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.